Adient
ADNT
299 hedge funds and large institutions have $2.94B invested in Adient in 2020 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 63 increasing their positions, 96 reducing their positions, and 38 closing their positions.
133% more funds holding in top 10
Funds holding in top 10: 3 → 7 (+4)
107% more capital invested
Capital invested by funds: $1.42B → $2.94B (+$1.52B)
95% more call options, than puts
Call options by funds: $109M | Put options by funds: $56.1M
82% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 38
10% more funds holding
Funds holding: 271 → 299 (+28)
2.18% more ownership
Funds ownership: 88.11% → 90.29% (+2.2%)
34% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 96
Top Buyers
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$93.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$68.7M |
| 3 |
GC
Greenvale Capital
London,
United Kingdom
|
+$33.8M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$30.2M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$28.9M |
Top Sellers
ADNT Hedge Fund Activity: Q4 2020 in Review
299 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Adient (ADNT) for Q4 2020, worth a combined $2.94B — up 107% from $1.42B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new ADNT positions and 38 closed out — a net gain of 31 holders — while 63 added to existing stakes and 96 trimmed.
The largest buyer was Nuveen, adding an estimated $93.6M. The largest seller was Barrow, Hanley, Mewhinney & Strauss, cutting an estimated $44M.
- 299 institutional investors held Adient (ADNT) as of Q4 2020, up from 271 in Q3 2020.
- Funds reported $2.94B of Adient stock for Q4 2020, up 107% quarter-over-quarter.
- 69 funds opened new Adient positions in Q4 2020 and 38 closed out, a net change of +31 holders.
- The largest Adient buyer in Q4 2020 was Nuveen, an estimated $93.6M added.
- The largest Adient seller in Q4 2020 was Barrow, Hanley, Mewhinney & Strauss, an estimated $44M sold.
Based on aggregated 13F filings for Q4 2020.